Pharma company FDC today said it is developing formulations for various geographies and also looking at opportunities in untapped areas and association in the global markets to boost its revenues. FDC is a fully integrated, research-oriented pharmaceutical company engaged in the manufacturing and marketing of formulations (finished dosage forms) and Active Pharmaceutical Ingredients (APIs). "The company is looking at various opportunities in untapped markets and association with business partners in the global markets to boost revenues," FDC chairman and managing director Mohan Chandavarkar said in the company's annual report. Our scientists work to develop formulations for various geographical markets namely India, ROW (rest of the world) and the regulated markets of US and Europe. The Indian Pharmaceutical Market (IPM) grew by 10.3 per cent to reach the market size of Rs 1,11,135 crore and around 3,297 products were introduced during FY17.

Source: dna August 20, 2017 09:11 UTC